The Medical Device Excise Tax - Over before It Begins?
and the Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital (A.S.K.) - all in Boston. New England Journal of Medicine
(Impact Factor: 55.87).
04/2013; 368(19). DOI: 10.1056/NEJMp1304175
In June 2012, the Supreme Court upheld critical provisions of the Affordable Care Act (ACA), which aims to expand health insurance to many of the 50 million currently uninsured Americans. With prospects dimming for legislative reversal of the entire law, the various stakeholders in the health care market are now focusing on its implementation. One of the numerous controversial elements to date has been the medical device excise tax, a 2.3% tax on domestic sales of medical devices, paid by the manufacturer, which went into effect in January 2013. Several categories of device sales are exempted, including purchases by government . . .
Available from: roth.com
Available from: Joshua M Adkinson
[Show abstract] [Hide abstract]
ABSTRACT: The Affordable Care Act is the largest and most comprehensive overhaul of the United States health care industry since the inception of the Medicare and Medicaid. Contained within the 10 titles are a multitude of provisions that will change how hand surgeons practice medicine and how they are reimbursed. It is imperative that surgeons are equipped with the knowledge of how this law will affect all physician practices and hospitals.
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.